The agency’s main drug review office cleared 50 novel medicines last year, short of 2018’s record total but on the higher end ...
Higher-income households with at least one user of GLP-1 class of weight loss drugs cut their grocery spending by nearly 9%, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback